Skip to Content
October 22, 2026

How We Approach Impact Investments in For-Profits

A growing number of promising organizations that work on biosecurity and navigating transformative AI are structured as for-profits. Some of these entities do important safety work that we want to support. We have two main options for supporting for-profit organizations, but each has downsides. 

The first is making non-dilutive grants, in which we don’t take any equity. The problem with such grants is that they are hard to make at scale and set poor incentives — giving non-dilutive grants to for-profits could attract founders who are less concerned about philanthropic impact relative to profit.

Then there’s the second option: impact investments. Investments into for-profit organizations are easier to make at scale and allow us to support a wider range of organizations while reducing the incentive effects of non-dilutive grants. They also help to ensure that the value our funding creates continues to serve charitable goals. With a grant, we can restrict the funding to a specific charitable purpose, but if the company becomes more valuable, that upside accrues to its other investors. Taking equity lets us capture some of that value and return it to philanthropy.

But holding equity in these organizations raises its own questions. Coefficient Giving also funds AI policy work, and using impact investments to obtain a financial stake in companies that stand to be affected by policy changes might pose a conflict of interest. And while we’ve reinvested proceeds from past investments into philanthropy, we want that commitment to be explicit from the start so that our AI policy work remains credibly independent.

Going forward, our standard practice will be that any resulting equity (or future equity) from our impact investments in for-profit AI and biosecurity companies will immediately be donated directly to the Against Malaria Foundation (AMF). Coefficient Giving will not retain any financial interest in the companies recommended for such impact investments, and profits generated by this funding will still serve charitable ends via AMF’s cost-effective global health work. We may revisit recipients in the future. By committing the equity to a specific charity up front, we make clear from the start of an investment that we have no financial stake in the outcome.

“We’re delighted to expand our relationship with Coefficient Giving,” says Rob Mather, CEO of AMF. “With this new policy, Coefficient has landed on a productive way to ensure that some benefits of AI reach people in low- and middle-income countries.” 

We expect to make several impact investments in the coming years across our AI and biosecurity fund areas. By default, we will take non-voting shares and donate them to AMF. This policy update allows us to support such work more wholeheartedly. 

Grants will remain our primary vehicle for supporting organizations, and this doesn’t change how we evaluate them; it just gives us another option when a for-profit structure is a better fit.